Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
80.28
+2.57 (3.31%)
At close: Nov 25, 2025, 4:00 PM EST
81.85
+1.57 (1.96%)
After-hours: Nov 25, 2025, 6:59 PM EST
Corcept Therapeutics Market Cap
Corcept Therapeutics has a market cap or net worth of $8.44 billion as of November 25, 2025. Its market cap has increased by 48.43% in one year.
Market Cap
8.44B
Enterprise Value
7.93B
1-Year Change
48.43%
Ranking
Category
Stock Price
$80.28
Market Cap Chart
Since April 14, 2004, Corcept Therapeutics's market cap has increased from $283.00M to $8.44B, an increase of 2,883.93%. That is a compound annual growth rate of 17.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 8.17B | 54.83% |
| Dec 31, 2024 | 5.28B | 57.69% |
| Dec 29, 2023 | 3.35B | 53.13% |
| Dec 30, 2022 | 2.19B | -4.35% |
| Dec 31, 2021 | 2.29B | -24.78% |
| Dec 31, 2020 | 3.04B | 119.78% |
| Dec 31, 2019 | 1.38B | -10.36% |
| Dec 31, 2018 | 1.54B | -25.15% |
| Dec 29, 2017 | 2.06B | 155.69% |
| Dec 30, 2016 | 806.10M | 48.81% |
| Dec 31, 2015 | 541.70M | 78.43% |
| Dec 31, 2014 | 303.60M | -5.24% |
| Dec 31, 2013 | 320.40M | 124.53% |
| Dec 31, 2012 | 142.70M | -50.47% |
| Dec 30, 2011 | 288.10M | 3.11% |
| Dec 31, 2010 | 279.40M | 60.85% |
| Dec 31, 2009 | 173.70M | 248.10% |
| Dec 31, 2008 | 49.90M | -59.17% |
| Dec 31, 2007 | 122.20M | 336.43% |
| Dec 29, 2006 | 28.00M | -66.22% |
| Dec 30, 2005 | 82.90M | -41.54% |
| Dec 31, 2004 | 141.80M | -49.89% |
| Apr 14, 2004 | 283.00M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |